Hicham Labazi

853 total citations
25 papers, 673 citations indexed

About

Hicham Labazi is a scholar working on Cardiology and Cardiovascular Medicine, Physiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Hicham Labazi has authored 25 papers receiving a total of 673 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 11 papers in Physiology and 6 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Hicham Labazi's work include Nitric Oxide and Endothelin Effects (10 papers), Pulmonary Hypertension Research and Treatments (6 papers) and Sodium Intake and Health (5 papers). Hicham Labazi is often cited by papers focused on Nitric Oxide and Endothelin Effects (10 papers), Pulmonary Hypertension Research and Treatments (6 papers) and Sodium Intake and Health (5 papers). Hicham Labazi collaborates with scholars based in United States, United Kingdom and Brazil. Hicham Labazi's co-authors include Michael W. Brands, R. Clinton Webb, Aaron J. Trask, Kênia Pedrosa Nunes, Cassandra Fleming, Jennifer S. Pollock, John D. Imig, Marlina Manhiani, Dexter L. Lee and Amy Banes‐Berceli and has published in prestigious journals such as The FASEB Journal, Hypertension and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Hicham Labazi

24 papers receiving 659 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hicham Labazi United States 10 219 214 134 113 111 25 673
Atilio Ferrebuz Venezuela 11 225 1.0× 249 1.2× 363 2.7× 141 1.2× 159 1.4× 19 930
Mariapina Pomilio Italy 10 138 0.6× 147 0.7× 68 0.5× 107 0.9× 73 0.7× 11 567
Camille M. Balarini Brazil 17 177 0.8× 79 0.4× 63 0.5× 155 1.4× 182 1.6× 27 618
M. A. Boim Brazil 9 354 1.6× 170 0.8× 57 0.4× 127 1.1× 151 1.4× 15 755
Melvin D. Lobo United Kingdom 17 569 2.6× 129 0.6× 158 1.2× 62 0.5× 112 1.0× 58 901
Jonathan Blau United States 10 333 1.5× 174 0.8× 324 2.4× 289 2.6× 175 1.6× 21 1.1k
Roxana Loperena United States 7 206 0.9× 163 0.8× 315 2.4× 104 0.9× 144 1.3× 10 768
Malte Ludwig Germany 17 344 1.6× 166 0.8× 66 0.5× 109 1.0× 104 0.9× 42 802
Justin P. Van Beusecum United States 13 200 0.9× 162 0.8× 304 2.3× 174 1.5× 261 2.4× 30 927

Countries citing papers authored by Hicham Labazi

Since Specialization
Citations

This map shows the geographic impact of Hicham Labazi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hicham Labazi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hicham Labazi more than expected).

Fields of papers citing papers by Hicham Labazi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hicham Labazi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hicham Labazi. The network helps show where Hicham Labazi may publish in the future.

Co-authorship network of co-authors of Hicham Labazi

This figure shows the co-authorship network connecting the top 25 collaborators of Hicham Labazi. A scholar is included among the top collaborators of Hicham Labazi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hicham Labazi. Hicham Labazi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Labazi, Hicham, et al.. (2021). Sex Differences in Pulmonary Hypertension. Clinics in Chest Medicine. 42(1). 217–228. 21 indexed citations
3.
Labazi, Hicham, Margaret Nilsen, & Margaret R. MacLean. (2021). Sex-dependent right ventricular hypertrophic gene changes after methamphetamine treatment in mice. European Journal of Pharmacology. 900. 174066–174066. 1 indexed citations
4.
Fisher, Simon, et al.. (2020). Direct Delivery of MicroRNA96 to the Lungs Reduces Progression of Sugen/Hypoxia-Induced Pulmonary Hypertension in the Rat. Molecular Therapy — Nucleic Acids. 22. 396–405. 5 indexed citations
5.
6.
Labazi, Hicham & Aaron J. Trask. (2017). Coronary microvascular disease as an early culprit in the pathophysiology of diabetes and metabolic syndrome. Pharmacological Research. 123. 114–121. 61 indexed citations
7.
Labazi, Hicham, Bunyen Teng, & S. Jamal Mustafa. (2017). Functional changes in vascular reactivity to adenosine receptor activation in type I diabetic mice. European Journal of Pharmacology. 820. 191–197. 8 indexed citations
8.
Wynne, Brandi M., Hicham Labazi, Zidonia N. Carneiro, Rita C. Tostes, & R. Clinton Webb. (2017). Angeli's Salt, a nitroxyl anion donor, reverses endothelin-1 mediated vascular dysfunction in murine aorta. European Journal of Pharmacology. 814. 294–301. 5 indexed citations
9.
Teng, Bunyen, Hicham Labazi, Changyan Sun, et al.. (2017). Divergent coronary flow responses to uridine adenosine tetraphosphate in atherosclerotic ApoE knockout mice. Purinergic Signalling. 13(4). 591–600. 5 indexed citations
10.
Labazi, Hicham, et al.. (2015). Role of Adenosine Receptor(s) in the Control of Vascular Tone in the Mouse Pudendal Artery. Journal of Pharmacology and Experimental Therapeutics. 356(3). 673–680. 12 indexed citations
11.
Labazi, Hicham, Bunyen Teng, Zhichao Zhou, & S. Jamal Mustafa. (2015). Enhanced A2A adenosine receptor-mediated increase in coronary flow in type I diabetic mice. Journal of Molecular and Cellular Cardiology. 90. 30–37. 16 indexed citations
12.
Zhou, Zhichao, Uthra Rajamani, Hicham Labazi, et al.. (2015). Involvement of NADPH oxidase in A2A adenosine receptor-mediated increase in coronary flow in isolated mouse hearts. Purinergic Signalling. 11(2). 263–273. 23 indexed citations
13.
Labazi, Hicham, Brandi M. Wynne, Rita C. Tostes, & R. Clinton Webb. (2013). Metformin Treatment Improves Erectile Function in an Angiotensin II Model of Erectile Dysfunction. The Journal of Sexual Medicine. 10(9). 2154–2164. 32 indexed citations
14.
Nunes, Kênia Pedrosa, Hicham Labazi, & R. Clinton Webb. (2012). New insights into hypertension-associated erectile dysfunction. Current Opinion in Nephrology & Hypertension. 21(2). 163–170. 89 indexed citations
15.
Wynne, Brandi M., Hicham Labazi, Rita C. Tostes, & R. Clinton Webb. (2011). Aorta from angiotensin II hypertensive mice exhibit preserved nitroxyl anion mediated relaxation responses. Pharmacological Research. 65(1). 41–47. 23 indexed citations
16.
Brands, Michael W., et al.. (2010). Interleukin 6 Knockout Prevents Angiotensin II Hypertension. Hypertension. 56(5). 879–884. 131 indexed citations
17.
Wynne, Brandi M., Hicham Labazi, Rita C. Tostes, & R. Clinton Webb. (2010). Nitroxyl anion mediates vasorelaxation in salt‐loaded AngII hypertensive mesenteric arteries. The FASEB Journal. 24(S1). 1 indexed citations
18.
Brands, Michael W. & Hicham Labazi. (2008). Role of Glomerular Filtration Rate in Controlling Blood Pressure Early in Diabetes. Hypertension. 52(2). 188–194. 6 indexed citations
19.
Brands, Michael W., et al.. (2007). LACK OF BLOOD PRESSURE SALT‐SENSITIVITY SUPPORTS A PREGLOMERULAR SITE OF ACTION OF NITRIC OXIDE IN TYPE I DIABETIC RATS. Clinical and Experimental Pharmacology and Physiology. 34(5-6). 475–479. 4 indexed citations
20.
Lee, Dexter L., Hicham Labazi, Cassandra Fleming, et al.. (2005). Angiotensin II hypertension is attenuated in interleukin-6 knockout mice. American Journal of Physiology-Heart and Circulatory Physiology. 290(3). H935–H940. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Atilio Ferrebuz Breakdown of academic impact, for papers by Mariapina Pomilio Breakdown of academic impact, for papers by Camille M. Balarini Breakdown of academic impact, for papers by M. A. Boim Breakdown of academic impact, for papers by Melvin D. Lobo Breakdown of academic impact, for papers by Jonathan Blau Breakdown of academic impact, for papers by Roxana Loperena Breakdown of academic impact, for papers by Malte Ludwig Breakdown of academic impact, for papers by Justin P. Van Beusecum
Rankless by CCL
2026